Concretely: SSA · ecnoglutide.
I want to understand what this actually establishes, as opposed to what it is being used to imply.
My concern is that I am being invited to draw a conclusion the data does not support.
What is the correct interpretation, and what is the common misreading?
The short version: peptides are supplied as salts, the salt is real mass, and neither purity nor a chromatogram will tell you how much of it there is.
Net peptide content — the fraction of gross mass that is the peptide itself — is the figure that folds water and counter-ion together and is what you should ask for if you ask for anything.
Quantification differs by ion: trifluoroacetate by ion chromatography or by fluorine nuclear magnetic resonance, acetate by ion chromatography or by capillary electrophoresis. Neither shows up on a UV chromatogram.
Peptides from reverse-phase purification with trifluoroacetic acid mobile phases are isolated as trifluoroacetate salts, which is standard synthesis practice.
Absence of a counter-ion figure is an absent measurement rather than a low one.
Ask for net peptide content. It folds water and counter-ion into one usable number.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsAnswering this needs the purification method, since a trifluoroacetic acid mobile phase leaves trifluoroacetate unless a deliberate exchange was performed.
Trifluoroacetate has documented biological effects at higher concentrations in cell culture, which is the technical reason acetate exchange exists rather than a marketing one.
The number of basic residues drives counter-ion load, because each protonated basic site pairs with one counter-ion. A sequence with several lysines and arginines carries proportionally more.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Trifluoroacetate unless a deliberate exchange was done. Ask which.
The underlying point is that acetate is generally preferred to trifluoroacetate for biological work, which is why the exchange is done at all.
Peptides purified by reverse-phase chromatography with a trifluoroacetic acid mobile phase are isolated as trifluoroacetate salts. The trifluoroacetate content depends on the number of basic residues and can run from a few per cent to well over ten by mass on a heavily basic sequence.
Worked reconciliation: a 10 mg vial at four per cent water and eight per cent trifluoroacetate contains 10.0 × 0.88 = 8.8 mg of peptide, a twelve per cent shortfall against label with a perfectly clean purity figure.
The caveat is that a purity figure is completely blind to counter-ion content, and the two are routinely conflated.
Count the basic residues and you can estimate the counter-ion load.
edited 10 Jul 2024 by nine_point_nine — fixed an arithmetic slip in the third paragraph
A net-peptide-content figure already accounts for it, which is why net content is the number worth asking for.
Acetate salts are produced by a deliberate ion exchange after purification. The exchange costs a processing step and is the reason acetate-form material is more expensive.
Net peptide content varies between lots as the process varies, so one figure does not characterise a supplier.
Purity says nothing about counter-ion. They are unrelated measurements.
The relevant arithmetic is that gross mass equals peptide plus counter-ion plus water, and the certificate usually reports only the first indirectly.
A supplier who reports both water and counter-ion has given you everything needed to reconcile the vial, and on this site that is a very short list.
Trifluoroacetate effects in cell culture are documented and are the technical basis for salt exchange to acetate.
Water plus counter-ion is why gross mass and peptide mass differ.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.